nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethionamide—Neurotoxicity—Teniposide—lymphatic system cancer	0.0609	0.0609	CcSEcCtD
Ethionamide—Neurotoxicity—Fludarabine—lymphatic system cancer	0.0536	0.0536	CcSEcCtD
Ethionamide—Optic neuritis—Fludarabine—lymphatic system cancer	0.0338	0.0338	CcSEcCtD
Ethionamide—Neurotoxicity—Vincristine—lymphatic system cancer	0.0327	0.0327	CcSEcCtD
Ethionamide—Digestion impaired—Fludarabine—lymphatic system cancer	0.0311	0.0311	CcSEcCtD
Ethionamide—Taste metallic—Methotrexate—lymphatic system cancer	0.0194	0.0194	CcSEcCtD
Ethionamide—Depression—Mechlorethamine—lymphatic system cancer	0.0179	0.0179	CcSEcCtD
Ethionamide—Jaundice—Mechlorethamine—lymphatic system cancer	0.0175	0.0175	CcSEcCtD
Ethionamide—Neuritis—Vincristine—lymphatic system cancer	0.017	0.017	CcSEcCtD
Ethionamide—Neurotoxicity—Methotrexate—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Ethionamide—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.013	0.013	CcSEcCtD
Ethionamide—Stomatitis—Teniposide—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Ethionamide—Gynaecomastia—Carmustine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Ethionamide—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Ethionamide—Stomatitis—Fludarabine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Ethionamide—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Ethionamide—Anorexia—Mechlorethamine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Ethionamide—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00994	0.00994	CcSEcCtD
Ethionamide—Diplopia—Carmustine—lymphatic system cancer	0.00965	0.00965	CcSEcCtD
Ethionamide—Agitation—Teniposide—lymphatic system cancer	0.00949	0.00949	CcSEcCtD
Ethionamide—Weight decreased—Bleomycin—lymphatic system cancer	0.00864	0.00864	CcSEcCtD
Ethionamide—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00842	0.00842	CcSEcCtD
Ethionamide—Agitation—Fludarabine—lymphatic system cancer	0.00834	0.00834	CcSEcCtD
Ethionamide—Stomatitis—Bleomycin—lymphatic system cancer	0.0083	0.0083	CcSEcCtD
Ethionamide—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Ethionamide—Anorexia—Teniposide—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Ethionamide—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00782	0.00782	CcSEcCtD
Ethionamide—Depression—Carmustine—lymphatic system cancer	0.00741	0.00741	CcSEcCtD
Ethionamide—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Ethionamide—Decreased appetite—Teniposide—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Ethionamide—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00729	0.00729	CcSEcCtD
Ethionamide—Vomiting—Mechlorethamine—lymphatic system cancer	0.00727	0.00727	CcSEcCtD
Ethionamide—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00727	0.00727	CcSEcCtD
Ethionamide—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Ethionamide—Stomatitis—Carmustine—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Ethionamide—Rash—Mechlorethamine—lymphatic system cancer	0.00721	0.00721	CcSEcCtD
Ethionamide—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0072	0.0072	CcSEcCtD
Ethionamide—Weight decreased—Vincristine—lymphatic system cancer	0.0072	0.0072	CcSEcCtD
Ethionamide—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00714	0.00714	CcSEcCtD
Ethionamide—Depression—Vincristine—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Ethionamide—Anorexia—Fludarabine—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Ethionamide—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00701	0.00701	CcSEcCtD
Ethionamide—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00696	0.00696	CcSEcCtD
Ethionamide—Stomatitis—Vincristine—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Ethionamide—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00691	0.00691	CcSEcCtD
Ethionamide—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00689	0.00689	CcSEcCtD
Ethionamide—Nausea—Mechlorethamine—lymphatic system cancer	0.00679	0.00679	CcSEcCtD
Ethionamide—Jaundice—Mitoxantrone—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Ethionamide—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Ethionamide—Abdominal pain—Teniposide—lymphatic system cancer	0.00666	0.00666	CcSEcCtD
Ethionamide—Dyspepsia—Fludarabine—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Ethionamide—Decreased appetite—Fludarabine—lymphatic system cancer	0.00644	0.00644	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Ethionamide—Hypersensitivity—Teniposide—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Ethionamide—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Ethionamide—Diarrhoea—Teniposide—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Ethionamide—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00551	0.00551	CcSEcCtD
Ethionamide—Vision blurred—Carmustine—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Ethionamide—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00546	0.00546	CcSEcCtD
Ethionamide—Vomiting—Teniposide—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Ethionamide—Agitation—Carmustine—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Ethionamide—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Ethionamide—Rash—Teniposide—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Ethionamide—Dermatitis—Teniposide—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Ethionamide—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00529	0.00529	CcSEcCtD
Ethionamide—Headache—Teniposide—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Ethionamide—Anorexia—Bleomycin—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Ethionamide—Agitation—Vincristine—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Ethionamide—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Ethionamide—Photosensitivity—Methotrexate—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Ethionamide—Diarrhoea—Fludarabine—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Ethionamide—Nausea—Teniposide—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Ethionamide—Decreased appetite—Bleomycin—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Ethionamide—Vomiting—Fludarabine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Ethionamide—Rash—Fludarabine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Ethionamide—Dermatitis—Fludarabine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Ethionamide—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Ethionamide—Headache—Fludarabine—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Ethionamide—Anorexia—Carmustine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Ethionamide—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Ethionamide—Nausea—Fludarabine—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Ethionamide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Ethionamide—Anorexia—Vincristine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Ethionamide—Somnolence—Carmustine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Ethionamide—Anorexia—Mitoxantrone—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Ethionamide—Decreased appetite—Carmustine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Ethionamide—Hypersensitivity—Bleomycin—lymphatic system cancer	0.004	0.004	CcSEcCtD
Ethionamide—Decreased appetite—Vincristine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Ethionamide—Somnolence—Mitoxantrone—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Ethionamide—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Ethionamide—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Ethionamide—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Ethionamide—Abdominal pain—Carmustine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Ethionamide—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Ethionamide—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Ethionamide—Abdominal pain—Vincristine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Ethionamide—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Ethionamide—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Ethionamide—Hypersensitivity—Carmustine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Ethionamide—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Ethionamide—Vomiting—Bleomycin—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Ethionamide—Drowsiness—Methotrexate—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Ethionamide—Depression—Methotrexate—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Ethionamide—Rash—Bleomycin—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Ethionamide—Dermatitis—Bleomycin—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Ethionamide—Stomatitis—Methotrexate—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Ethionamide—Hypersensitivity—Vincristine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Ethionamide—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Ethionamide—Diarrhoea—Carmustine—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Ethionamide—Nausea—Bleomycin—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Ethionamide—Dizziness—Carmustine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Ethionamide—Diarrhoea—Vincristine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Ethionamide—Hepatitis—Methotrexate—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Ethionamide—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Ethionamide—Vomiting—Carmustine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Ethionamide—Dizziness—Vincristine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Ethionamide—Rash—Carmustine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Ethionamide—Dermatitis—Carmustine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Ethionamide—Headache—Carmustine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Ethionamide—Vomiting—Vincristine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Ethionamide—Rash—Vincristine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Ethionamide—Dermatitis—Vincristine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Ethionamide—Headache—Vincristine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Ethionamide—Nausea—Carmustine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Ethionamide—Vomiting—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Ethionamide—Rash—Mitoxantrone—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Ethionamide—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Ethionamide—Headache—Mitoxantrone—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Ethionamide—Nausea—Vincristine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Ethionamide—Dysgeusia—Methotrexate—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Ethionamide—Nausea—Mitoxantrone—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Ethionamide—Vision blurred—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Ethionamide—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Ethionamide—Anorexia—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Ethionamide—Somnolence—Methotrexate—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Ethionamide—Dyspepsia—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Ethionamide—Decreased appetite—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Ethionamide—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Ethionamide—Abdominal pain—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Ethionamide—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Ethionamide—Diarrhoea—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Ethionamide—Dizziness—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Ethionamide—Vomiting—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Ethionamide—Rash—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Ethionamide—Dermatitis—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Ethionamide—Headache—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Ethionamide—Nausea—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
